Contact: Melissa Kadish, Press Secretary
email@example.com For Immediate Release
Mar 22, 2012
ZERO Elects New Member to Board of Directors
Washington D.C. – Robert Ginyard of Baltimore, MD, is a new member of ZERO – The Project to End Prostate Cancer’s Board of Directors.
Ginyard is a prostate cancer survivor and the inventor of the Shusokumb (pronounced Shu- Sock’em) Bag, a compartmentalized tote bag designed for the millions of women who wear flat shoes or sneakers to work and later change into heels once they arrive to the office.
Ginyard was diagnosed with prostate cancer at the age of 48. After his diagnosis, he decided to take on a new role in speaking out to promote prostate cancer awareness and overall good health. Ginyard now says he owes it to other men and their families to share his experiences, including tackling major issues such as sex, love, and life after prostate cancer head-on.
“I’m honored to be a part of an organization that is making great strides in raising awareness of prostate cancer. Through their early testing outreach, research, and advocacy, they’re saving lives. “
Ginyard worked as a banker, and Director of Marketing for a national trade association before launching his own tote bag business. He is a frequent guest on radio programs sharing his expertise on entrepreneurship, marketing, and his prostate cancer journey. Ginyard lives in Baltimore with his wife and two daughters.
About ZERO — The Project to End Prostate Cancer (zerocancer.org)
At ZERO, we commit ourselves not only to reduce prostate cancer or alleviate the pain from the disease, but also to end it. We see a future where all men who have been diagnosed with prostate cancer will be cured or manage their illness with good quality of life; with the support they need to minimize physical and emotional suffering, and to cope effectively throughout their cancer journey. To accomplish our goal, we provide comprehensive treatment information to patients, education to those at risk and conduct free prostate cancer testing throughout the country. We increase research funds from the federal government to find new treatments and we fund local grants to end the disease.